Endoron Medical Secures $10 Million in Series A Funding to Propel Breakthrough Endovascular Solution
In a significant stride towards revolutionizing the treatment of abdominal aortic aneurysms (AAA), Endoron Medical has announced the successful closure of a $10 million Series A funding round. Led by Sofinnova Partners and bolstered by contributions from the European Innovation Council Fund, this funding marks a pivotal moment for Endoron as it accelerates the development…